Sage Therapeutics Inc (SAGE) — Capital Reinvestment Ratio
Latest as of December 2020:
0.00x
Sage Therapeutics Inc (SAGE) has a Capital Reinvestment Ratio of 0.00x as of December 2020, meaning it reinvests 0% of its operating cash flow ($1.01 Billion) in capital expenditures ($1.00K). See Sage Therapeutics Inc (SAGE) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.00x
Capex / Operating Cash Flow
Operating Cash Flow
$1.01 Billion
USD
Capital Expenditures
$1.00K
USD
Data as of
Dec 2020
Most recent filing
Sage Therapeutics Inc Capital Reinvestment Ratio (2020–2020)
This chart tracks Sage Therapeutics Inc's Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for Sage Therapeutics Inc (2020–2020)
Year-by-year Capital Reinvestment Ratio for Sage Therapeutics Inc from 2020 to 2020. For live market cap and broader valuation context, see SAGE stock market capitalisation.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2020 | 0.00x | $664.28 Million | $345.00K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow